Permanent alopecia after busulfan chemotherapy

British Journal of Dermatology

Volumn 152, Issue 5, 2005, Pages 1056-1058

  Tosti, Antonella ^a   Piraccini, B M ^a   Vincenzi, C ^a   Misciali, C ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Alopecia; Busulfan; Chemotherapy; Hair loss

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; MELPHALAN; MINOXIDIL;

ADULT; ALOPECIA; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CASE REPORT; CELL DAMAGE; CELL DESTRUCTION; FEMALE; FIBROSIS; HAIR FOLLICLE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; KERATINOCYTE; MYELOABLATIVE CONDITIONING; PERMANENT ALOPECIA; PRIORITY JOURNAL; STEM CELL;

ADULT; ALOPECIA; ANTINEOPLASTIC AGENTS, ALKYLATING; BONE MARROW TRANSPLANTATION; BUSULFAN; FEMALE; HUMANS; TRANSPLANTATION CONDITIONING;

EID: 18944398919     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2005.06469.x     Document Type: Article

References (10)

1. Editorial. Cancer, cancer therapy and hair. Lancet 1983; ii:1177-8.
2. Grossman KL, Kvedar JC. Anagen hair loss. In: Disorders of Hair Regrowth: Diagnosis and Treatment (Olsen EA, ed.). New York: McGraw-Hill, 1994; 223-39.
3. Wheeland RG, Burgdorf WHC, Humphrey GB. The flag sign of chemotherapy. Cancer 1983; 51:1356-8.
4. Bravermann IM. Leukemia and allied disorders. In: Skin Signs of Systemic Disease (Bravermann IM, ed.), 3rd edn. Philadelphia: W.B. Saunders, 1988; 131-47.
5. Baker BW, Wilson CL, Davis AL et al. Busulphan/cyclophosphamide conditioning for bone marrow transplantation may lead to failure of hair regrowth. Bone Marrow Transplant 1991; 7:43-7.
6. Tran D, Sinclair RD, Schwarer AP, Chow CW. Permanent alopecia following chemotherapy and bone marrow transplantation. Australas J Dermatol 2000; 41:106-8.
7. Ljungman P, Hassan M, Bekassy AN et al. Busulphan concentration in relation to permanent alopecia in recipients of bone marrow transplants. Bone Marrow Transplant 1995; 15:869-71.
8. Whiting DA. Chronic telogen effluvium: increased scalp hair shedding in middle-aged women. J Am Acad Dermatol 1996; 35:899-906.
9. Hartsell WF, Czyzewski EA, Ghalie R, Kaizer H. Pulmonary complications of bone marrow transplantation: a comparison of total body irradiation and cyclophosphamide to busulphan and cyclophosphamide. Int J Rad Oncol Biol Phys 1995; 32:69-73.
10. Morgan M, Dodds A, Atkinson K et al. The toxicity of busulphan and cyclophosphamide as preparative regimen for bone marrow transplantation. Br J Haematol 1991; 77:529-34.